CSPC Pharmaceutical Says SYS6062 Receives Clinical Trial Approval in China
CSPC Pharmaceutical said its SYS6062 program received clinical trial approval in China.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.